SIC
CVS icon

Samalin Investment Counsel’s CVS Health CVS Stock Holding History

Samalin Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
+12,860
New +$1.15M 0.42% 65
2024
Q4 		– Sell
-4,008
Closed -$252K – 300
2024
Q3 		$252K Sell
4,008
-1,164
-23% -$67.9K 0.11% 242
2024
Q2 		$305K Sell
5,172
-57
-1% -$3.57K 0.14% 214
2024
Q1 		$417K Sell
5,229
-138
-3% -$10.5K 0.2% 173
2023
Q4 		$424K Sell
5,367
-208
-4% -$14.8K 0.21% 159
2023
Q3 		$389K Buy
5,575
+287
+5% +$20.3K 0.22% 135
2023
Q2 		$366K Sell
5,288
-254
-5% -$18.1K 0.2% 144
2023
Q1 		$412K Sell
5,542
-318
-5% -$26.7K 0.25% 122
2022
Q4 		$546K Sell
5,860
-208
-3% -$20.1K 0.35% 88
2022
Q3 		$579K Buy
6,068
+335
+6% +$33.2K 0.42% 65
2022
Q2 		$531K Buy
5,733
+17
+0.3% +$1.66K 0.37% 74
2022
Q1 		$579K Sell
5,716
-20
-0.3% -$2.1K 0.35% 80
2021
Q4 		$592K Sell
5,736
-201
-3% -$18.6K 0.36% 80
2021
Q3 		$504K Buy
5,937
+107
+2% +$8.96K 0.33% 98
2021
Q2 		$487K Sell
5,830
-1,005
-15% -$82.3K 0.32% 102
2021
Q1 		$514K Buy
6,835
+255
+4% +$18.6K 0.34% 97
2020
Q4 		$449K Buy
6,580
+288
+5% +$18.7K 0.34% 94
2020
Q3 		$367K Buy
6,292
+386
+7% +$24K 0.33% 100
2020
Q2 		$383K Sell
5,906
-679
-10% -$42.8K 0.4% 73
2020
Q1 		$390K Buy
6,585
+1,667
+34% +$111K 0.52% 60
2019
Q4 		$365K Buy
+4,918
New +$345K 0.31% 89

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Samalin Investment Counsel's CVS Position: Q2 2026 in Review

Samalin Investment Counsel opened a new position in CVS Health (CVS) in Q2 2026: 12,860 shares worth $1.33M. The stake represents 0.42% of the portfolio and ranks #65 among its holdings. This is a return to the name: Samalin Investment Counsel previously reported a position in CVS as recently as Q3 2024.

Samalin Investment Counsel first reported a position in CVS in Q4 2019 and has held it in 21 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Samalin Investment Counsel held 12,860 shares of CVS Health worth $1.33M as of Q2 2026.
  • CVS Health was a new Samalin Investment Counsel position in Q2 2026.
  • CVS Health made up 0.42% of Samalin Investment Counsel's portfolio in Q2 2026, its #65 holding.
  • Samalin Investment Counsel first reported a position in CVS Health in Q4 2019 and has held it in 21 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.